What does chronic hepatitis C statosis mean?;Quelle est la signification de la stéatose dans l'hépatite chronique C?

Gastroenterologie Clinique et Biologique

Volumn 27, Issue 12, 2003, Pages 1073-1075

  Asselah, Tarik ^a   Ripault, Marie Pierre ^a   Marcellin, Patrick ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC HEPATITIS; CLINICAL RESEARCH; DISEASE ASSOCIATION; EDITORIAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; PATHOPHYSIOLOGY; STEATOSIS;

DISEASE PROGRESSION; FATTY LIVER; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; RISK FACTORS;

EID: 1642435259     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (17)

1. Hézode C, Castera L, Chouteau P, Dhumeaux D, Pawlotsky JM. Stéatose et Hépatite C. Gastroenterol Clin Biol 2003;XXX-XXX.
2. Asselah T, Boyer N, Marcellin P. Steatosis in Hepatitis C. What does it mean?. Current Hepatitis Reports 2003;2:137-44.
3. Mihm S, Fayyazi A, Hartmann H, Ramadori G. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology 1997;25:735-9.
4. Rubbia-Brandt L, Quadri R, Abid K, Abid K, Giostra E, Mala PJ et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol 2000;33:106-15.
5. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001;33:1358-64.
6. Kumar D, Farrell GC, Fung C, George J. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: reversal of hepatic steatosis after sustained therapeutic response. Hepatology 2002;36:1266-72.
7. Poynard T, Ratziu V, McHutchison J, Manns M, Goodman Z, Zeuzem S, et al. Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. Hepatology 2003;38:75-85.
8. Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuura Y et al. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA 1997;94:1200-5.
9. Shi ST, Polyak SJ, Tu H, Taylor DR, Gretch DR, Lai MM. Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology 2002;292:198-210.
10. Perlemuter G, Sabile A, Letteron P, Vona G, Topilco A, Chretien Y et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 2002;16:185-94.
11. Lerat H, Honda M, Beard MR, Loesch K, Sun J, Yang Y et al. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 2002;122:352-65.
12. Okuda M, Li K, Beard MR, Showalter LA, Scholk F, Lemon SM et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002;122:366-75.
13. Castéra L, Hézode C, Roudot-Thoraval F, Bastie A, Zafrani E, Pawlotsky JM et al. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 2003;52:288-92.
14. Asselah T, Boyer N, Guimont MC, Cazals-Hatem D, Tubach F, Nahon K, et al. Liver fibrosis is not associated with steatosis but with necroinflammation in french patients with chronic hepatitis C. Gut 2003;52(11):1638-43.
15. Rubbia-Brandt L, Fabris P, Paganin S, et al. Steatosis affects chronic hepatitis C progression in a genotype-specific way. Gut, in press.
16. Monto A, Alonzo J, Watson JJ, Grunfeld C, Wright TL. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol. Hepatology 2002;36:729-36.
17. Bressler BL, Guindi M, Tomlinson G, Heathcote J. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. Hepatology 2003;38:639-44.